Nektar Therapeutics announced that John Northcott will step down as Senior Vice President and Chief Commercial Officer of the Company in June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | -3.70% | -17.72% | +130.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+130.09% | 242M | |
+27.97% | 672B | |
+24.18% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.15% | 211B | |
-0.31% | 203B | |
-10.14% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- John Northcott Step Down as Senior Vice President and Chief Commercial Officer of Nektar Therapeutics